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 34 
Abstract  35 
Staphylococcus pseudintermedius is the leading cause of pyoderma in dogs and is often associated 36 
with recurrent skin infections that require prolonged antibiotic therapy. High levels of antibiotic use 37 
have led to multidrug resistance including the emergence of epidemic methicillin-resistant clones. 38 
Our understanding of the pathogenesis of S. pseudintermedius skin infection is very limited and the 39 
identification of the key host-pathogen interactions underpinning infection could lead to the design 40 
of novel therapeutic or vaccine-based approaches for controlling disease. Here, we employ a novel 41 
murine cutaneous infection model of S. pseudintermedius and investigate the role of the two cell 42 
wall-associated proteins (SpsD and SpsL) in skin disease pathogenesis. Experimental infection with 43 
wildtype S. pseudintermedius strain ED99, or a gene-deletion derivative deficient in expression of 44 
SpsD, led to a focal accumulation of neutrophils and necrotic debris in the dermis and deeper 45 
tissues of the skin, characteristic of a classical cutaneous abscess. In contrast, mice infected with 46 
mutants deficient in SpsL or both SpsD and SpsL developed larger cutaneous lesions with distinct 47 
histopathological features of regionally extensive cellulitis rather than focal abscessation. 48 
Furthermore, comparison of the bacterial load in S. pseudintermedius-induced cutaneous lesions 49 
revealed a significantly increased burden of bacteria in the mice infected with SpsL-deficient 50 
mutants. These findings reveal a key role for SpsL in murine skin abscess formation and highlight a 51 
novel function for a bacterial surface protein in determining the clinical outcome and pathology of 52 
infection caused by a major canine pathogen.  53 
 54 
 55 
 56 
 57 
 58 
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 59 
Introduction 60 
Staphylococcus pseudintermedius, a coagulase-positive species, is a natural commensal of 61 
the skin and mucosal membranes of dogs with healthy carriage rates reported to range from 46% - 62 
92% (1). S. pseudintermedius is capable of causing a range of opportunistic infections including 63 
urinary tract, ear, wound, and surgery-related infections (1). The most clinically important 64 
consequence of S. pseudintermedius infection is canine pyoderma with approximately 10% of dogs 65 
affected worldwide (2). Canine pyoderma is an umbrella term used to describe a range of clinical 66 
manifestations, most commonly superficial bacterial folliculitis and atopic dermatitis, which are 67 
often treated with antibiotics alongside topical creams and shampoos containing antimicrobial 68 
agents such as chlorhexidine (3, 4). The repeated use of antibiotics in patients with recurrent 69 
pyoderma is linked to the development of antibiotic resistance and the rapid global spread of 70 
methicillin resistant S. pseudintermedius (MRSP), with some strains developing resistance to all 71 
commonly used antimicrobials in veterinary medicine (5-8). The high prevalence of multidrug 72 
resistant S. pseudintermedius is a major concern for the continued treatment of canine pyoderma. 73 
Our understanding of the pathogenesis of S. pseudintermedius infection and the key bacterial 74 
factors involved is very limited. Exfoliative toxins ExpA and ExpB, cause intra-epidermal clefts in 75 
the skin by directly cleaving canine desmoglein 1 and both intradermal and subcutaneous injection 76 
of either exfoliative toxin, in dogs, leads to the development of clinical manifestations of pyoderma 77 
including crusting and erythema (9-11). Bacterial adhesins are also thought to be important as the S. 78 
pseudintermedius clinical isolate ED99 demonstrates increased adherence to pyoderma-associated 79 
canine corneocytes when compared with healthy corneocytes (12). Of the 18 cell wall-associated 80 
(CWA) proteins encoded in the genome sequence of S. pseudintermedius clinical isolate ED99, two 81 
have been demonstrated to mediate binding to host proteins (13). S. pseudintermedius surface 82 
proteins D and L (SpsD and SpsL), mediate binding to the host extracellular matrix proteins 83 
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fibrinogen, fibronectin, and the cytoskeletal protein cytokeratin-10 when expressed by the 84 
heterologous host Lactococcus lactis (13). Recombinant versions of the SpsD N-terminal A-domain 85 
interfere with fibrin clot formation and platelet aggregation in vitro and both SpsD and SpsL are 86 
sufficient for the invasion of S. pseudintermedius into canine progenitor epidermal keratinocytes in 87 
a fibronectin-dependent manner in vitro (14, 15). To date, the role of S. pseudintermedius putative 88 
virulence factors have not been examined during experimental infection.  89 
Skin infection models have been employed previously to analyse the role of CWA proteins 90 
of Staphylococcus aureus by subcutaneous injection of wildtype and gene deletion strains (16-18). 91 
In these studies, mice develop focal skin abscesses and dermonecrosis within 24 h that subsequently 92 
resolve spontaneously after 14 d in the absence of a systemic response (16). These skin lesions can 93 
be evaluated using histopathology or homogenised to determine the number of viable bacteria 94 
present. Here we develop the first murine infection model of S. pseudintermedius and assess the 95 
role of SpsD and SpsL in this murine model using single and double deletion strains of spsD and 96 
spsL in the S. pseudintermedius clinical isolate ED99, originally isolated in the UK from a dog 97 
affected by canine pyoderma (12). We discovered that the wildtype and spsD-deficient-infected 98 
mice developed classical abscessation near the inoculation site. In contrast, mice inoculated with 99 
spsL-deficient or spsLspsD-deficient strains, developed an alternative clinical pathology described 100 
as cellulitis. These findings demonstrate that a bacterial CWA protein determines the clinical 101 
outcome of infection in a novel murine cutaneous model.   102 
 103 
 104 
Results  105 
SpsD and SpsL of S. pseudintermedius ED99 Adhere to Murine Fibronectin, 106 
Fibrinogen, and Cytokeratin-10. Previous work demonstrated that S. pseudintermedius SpsD and 107 
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SpsL can mediate binding to extracellular matrix proteins fibronectin and fibrinogen and the 108 
cytoskeletal protein cytokeratin-10, when expressed on the surface of a heterologous host L. lactis 109 
(2). To determine if murine skin was a suitable model for the analysis of SpsD and SpsL, we 110 
examined their capacity to mediate binding to the murine proteins fibronectin, fibrinogen, and 111 
cytokeratin-10. The expression of SpsD and SpsL on the surface of L. lactis mediated binding to 112 
murine fibronectin, fibrinogen, and cytokeratin-10, with SpsD demonstrating stronger binding to 113 
murine cytokeratin-10 and fibrinogen than SpsL (Fig. 1A and B). This suggests that the role of 114 
SpsD and SpsL in the pathogenesis of S. pseudintermedius canine pyoderma can be examined in a 115 
murine infection model.  116 
In order to examine the importance of SpsD and SpsL in mediating binding of S. 117 
pseudintermedius ED99 to the same murine ligands, we performed solid phase bacterial adherence 118 
assays with wildtype, and single or double spsL and spsD deletion mutants (15). Expression 119 
analysis demonstrated that SpsD is expressed on the cell surface at early exponential phase (OD600 120 
of 0.2) with SpsL expressed on the cell surface throughout the exponential phase (data not shown). 121 
Accordingly, the binding potential of CWA SpsD and SpsL were investigated by solid phase 122 
adherence assays at early exponential growth phase. As expected, S. pseudintermedius ED99 123 
demonstrated adherence to murine fibronectin, murine fibrinogen, and murine cytokeratin-10 (Fig. 124 
1C-1E). Equivalent murine fibronectin binding to the wildtype was observed for ED99∆spsD 125 
demonstrating that SpsL is promoting binding to fibronectin (Fig. 1C). However, ED99∆spsL 126 
retains a reduced adherence to fibronectin demonstrating that SpsD is sufficient for fibronectin-127 
binding (Fig. 1C). Adherence to murine fibrinogen was reduced in comparison to the other ligands 128 
with both ED99∆spsD and ED99∆spsL exhibiting reduced binding suggesting that both SpsL and 129 
SpsD, respectively, are capable of mediating adherence to murine fibrinogen (Fig. 1D). 130 
Surprisingly, ED99∆spsL exhibits poor binding to cytokeratin-10 suggesting that SpsL is the main 131 
mediator of cytokeratin-10 binding (Fig. 1E). Of note, ED99∆spsL∆spsD demonstrated complete 132 
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ablation of binding to all three ligands confirming that SpsD and SpsL are the only CWA proteins 133 
of S. pseudintermedius ED99 promoting adherence to murine fibronectin, fibrinogen, and 134 
cytokeratin-10 under these assay conditions (Fig. 1A-C).  135 
Development of a Murine Cutaneous Infection Model of S. pseudintermedius ED99. 136 
Initially, pilot experiments were performed to develop the first murine skin infection model of S. 137 
pseudintermedius. Female BALB/c mice received an injection of either 100 µl volume PBS or 138 
1x10
7 
CFU of S. pseudintermedius ED99 (in 100 µl PBS) as a bolus into the subcutaneous tissue of 139 
the dorsal midline, just caudal to the interscapular region. Mice were then monitored for 4 d post-140 
infection (dpi) to determine the severity of the disease and follow the development of skin lesions. 141 
The wildtype-infected mice exhibited a trend towards greater weight loss than the control mice but 142 
this was not significant suggesting that a systemic infection did not occur (Fig. 2A), and there were 143 
no differences in the size of excised spleens (Fig. S1A). Cutaneous lesions in the wildtype-infected 144 
mice became visible on the back or flank of the mouse at 2 dpi and became more prominent by 4 145 
dpi (Fig. 2B). The gross pathology was typified by a soft cutaneous lesion of varying shape up to 9 146 
mm along the longest axis, unattached to the underlying tissue, and with a well-defined, reddened 147 
margin. On the cut surface there were one or 2 circumscribed, round, soft to liquid areas (pus) 148 
approximately 1-2 mm diameter within the dermis and subcutis underlying the lesion.  149 
A subset of mice were euthanised at 1, 2, and 4 dpi and the dorsal cutaneous tissue excised, 150 
fixed in 10 % formal saline and processed using standard procedures to tissue sections which were 151 
then stained with haematoxylin and eosin and examined by a veterinary pathologist (P.M.B). No 152 
significant pathology was identified in the tissue from the control mice (Fig. 2C). Wildtype-infected 153 
mice developed classic skin abscesses characterised by a focal accumulation of neutrophils (some 154 
degenerate), cellular debris and bacteria (Fig. 2D), with no appreciable differences in size or disease 155 
severity over time (Fig. S1 B and C). This pilot study demonstrated that S. pseudintermedius-156 
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infected mice develop classic cutaneous abscesses similar to those clinically described in dogs 157 
affected by S. pseudintermedius pyoderma (3). 158 
Infection with S. pseudintermedius Lacking SpsD and SpsL Cell Wall-associated 159 
Proteins Results in a Distinct Skin Infection Pathology. The murine S. pseudintermedius skin 160 
infection model was used to determine the role of bacterial CWA proteins in the pathogenesis of 161 
cutaneous infection. Female BALB/c mice were injected subcutaneously as described previously 162 
with either S. pseudintermedius wildtype or the derivative ED99∆spsL∆spsD deletion mutant and 163 
monitored for 3 dpi. The mice infected with the ED99∆spsLΔspsD strain lost more body weight 164 
than the mice infected with the wildtype strain at all three time points (p≤0.05 at 2 dpi)  (Fig. 3A). 165 
Gross examination of the site of inoculation revealed that the wildtype-infected mice developed 166 
raised, soft cutaneous lesions with a reddened margin similar to those described in the pilot 167 
experiments above. In comparison, ED99∆spsLΔspsD-infected mice developed flattened, 168 
longitudinally extended cutaneous lesions that covered a larger area (Fig. S2). Measurement of the 169 
cutaneous lesions along the longest axis confirmed that ED99∆spsL∆spsD-infected mice develop 170 
significantly longer lesions than wildtype-infected mice at both 2 and 3 dpi (p≤0.001) (Fig. 3B). 171 
Histopathological examination of the inoculated area in mice infected with the wildtype strain 172 
revealed the presence of focal, well circumscribed abscesses consistent with that observed in the 173 
pilot study (Fig. 3C). However, focal abscess formation was not observed in the ED99∆spsL∆spsD-174 
infected mice, which instead revealed cellulitis characterised by poorly delineated, regionally 175 
extensive areas of suppurative inflammation accompanied by abundant necrotic debris, particularly 176 
in the deeper cutaneous layers (Fig. 3C). The inflammatory infiltrate extended laterally between 177 
tissue planes. Both distinct pathology types, abscessation and cellulitis, contained neutrophils as the 178 
predominant inflammatory cell (Fig. 3C). No differences in spleen length or infection severity 179 
between infection groups was recorded with wide within-group variation observed (Fig. S3A and 180 
B).  The categorisation of cellulitis correlated with larger histopathological lesions in 181 
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ED99∆spsL∆spsD-infected mice in comparison to wildtype-infected mice at both 2 (p≤0.05) and 3 182 
dpi (p≤0.0001) (Fig. 3D). Categorising the histopathological changes into abscessation or cellulitis 183 
confirmed decreased abscess formation in ED99ΔspsLΔspsD-infected mice (p≤0.005) (Fig. 3E). 184 
These data suggest that formation of a focal abscess after cutaneous inoculation in mice is 185 
dependent on expression of one or more CWA proteins.  186 
SpsL is Required for the Development of Skin Abscesses in a Murine Infection Model. 187 
In order to investigate the relative role of SpsD and SpsL, single gene deletion mutants, 188 
ED99∆spsD and ED99∆spsL, were employed. Ten female BALB/c mice were inoculated with 189 
either wildtype, ED99∆spsD, ED99∆spsL, or ED99∆spsL∆spsD strains of S. pseudintermedius as 190 
described above, monitored, and euthanized at 1, 2, and 3 dpi. Measurement of body weight and 191 
cutaneous lesion length demonstrated that ED99∆spsD-infected mice displayed characteristics more 192 
similar to the wildtype-infected mice, while both the ED99∆spsL- and ED99∆spsL∆spsD-infected 193 
mice displayed decreased body weight (Fig. 4A), and increased lesion length (p≤0.001) (Fig 4B) in 194 
comparison to wildtype-infected mice. Although upon histopathological examination no differences 195 
in histopathology lesion length were identified (Fig. 4C), clear differences were observed in the 196 
type of histopathology present between experimental groups (Fig 4D). The wildtype- and 197 
ED99∆spsD-infected mice were more likely to develop abscesses, and the ED99∆spsL- and 198 
ED99∆spsL∆spsD-infected mice were more likely to develop cellulitis (p≤0.01) (Fig. 4D).  199 
To confirm the role of SpsL in abscess formation and fulfil Molecular Koch’s postulates 200 
(19), the spsL gene was re-introduced to the ED99∆spsL strain by allele replacement as described in 201 
the Materials and Methods. The ED99∆spsL Repaired (Rep) strain demonstrated restored SpsL 202 
surface expression and bacterial adherence to canine fibrinogen allowing analysis in the murine 203 
model alongside the wildtype and ED99∆spsL strain using the same experimental setup as above 204 
(Fig. S4). Gross examination identified no differences in the body weight of mice from all 205 
experimental groups (Fig. 5A). However, there were raised, soft cutaneous lesions with a reddened 206 
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margin present at the inoculation site of the ED99∆spsL Rep-infected mice similar to the wildtype-207 
infected mice with the ED99∆spsL-infected mice demonstrating flattened, cutaneous lesions that 208 
were significantly longer at 1 (p≤0.05) and 2 dpi (p≤0.001) (Fig. 5B). Histopathological 209 
examination confirmed that ED99∆spsL Rep-infected mice were more likely to develop abscesses 210 
than ED99∆spsL-infected mice (p≤0.001) (Fig. 5C). These data indicate that SpsL is the first S. 211 
pseudintermedius virulence factor to be described and that SpsL plays a key role in determining the 212 
pathology of S. pseudintermedius infection in this murine cutaneous model.  213 
Cellulitis is Linked with Increased Bacterial Load. In order to quantify the number of 214 
viable bacteria associated with the two observed pathology types, the above experiment involving 4 215 
experimental groups, was repeated. At 1, 2, and 3 dpi the mice were euthanised, the cutaneous 216 
lesion on the dorsal midline excised, homogenised, and cultured to determine the number of live 217 
bacteria present in the tissue (total CFU/lesion). The same gross observations were identified 218 
relating to larger lesions in ED99∆spsL- and ED99∆spsL∆spsD-infected mice in comparison to 219 
wildtype- and ED99∆spsD-infected mice (data not shown). In addition, increased bacterial load was 220 
identified in ED99∆spsL- and ED99∆spsL∆spsD-infected mice in comparison to wildtype- and 221 
ED99∆spsD-infected mice at 2 and 3 dpi (p≤0.001) (Fig. 6). Importantly, mice infected with a 222 
strain with a restored spsL gene, ED99∆spsL Rep, had less bacteria present in the cutaneous lesion 223 
in comparison to ED99∆spsL-infected mice at 1 (p≤0.05), 2 (p≤0.001), and 3 dpi (p≤0.01) and with 224 
similar numbers to wildtype-infected mice (Fig. 5D). These data reveal an association between 225 
pathology and bacterial burden that is dependent on SpsL.  226 
 227 
 228 
Discussion 229 
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The global dissemination of multidrug resistant MRSP strains is making it increasingly 230 
difficult to treat canine pyoderma. There are also increasing reports of human-related infections 231 
caused by S. pseudintermedius and colonisation of veterinary staff (20-22). Similarly to dogs, skin 232 
and soft tissue infections, including abscess formation, are the most common form of disease caused 233 
by S. pseudintermedius in humans (20, 22). However, some more invasive infections have also been 234 
reported including bloodstream-infection and cellulitis (20, 23). If much-needed novel therapeutics 235 
are to be developed to combat MRSP then a greater understanding of the critical host-pathogen 236 
interactions leading to the development of canine pyoderma and human skin and soft tissue 237 
infections is required. Here we have established the first murine model of S. pseudintermedius skin 238 
infection. Subcutaneous injection of S. pseudintermedius ED99 led to the development of focal skin 239 
abscesses (Fig. 2B) similar to those observed after subcutaneous injection of S. aureus (24). We 240 
identified that while SpsD is dispensable, SpsL is required for the development of classic S. 241 
pseudintermedius skin abscesses in the murine model.  242 
A common feature of S. aureus cutaneous infection models is the development of 243 
dermonecrosis, depending on the inoculum dose and bacterial strain used (16, 25). S. aureus 244 
dermonecrosis is dependent on toxins such as the α-toxin and the α-type phenol-soluble modulins, 245 
with mice infected with strains deficient in hla or psmα genes unable to develop dermonecrosis (26-246 
28). No dermonecrosis was evident in this study but necrosis was identified that typically involved 247 
the epidermis but was also variably associated with underlying cutaneous layers. This necrosis of 248 
the epidermis was present in all experimental groups and was not associated with the development 249 
of a particular type of pathology. This demonstrates that the development of cellulitis is not linked 250 
with changes in the level of epidermal necrosis and that the dermonecrosis discussed in the S. 251 
aureus literature is not akin to the cellulitis phenotype described here.   252 
Clinically, abscess formation and cellulitis are distinct phenotypes that can present 253 
simultaneously and can be both acute and chronic (24). Abscesses encase the bacteria in a confined 254 
location while cellulitis is more likely to affect a larger area of the skin with diffuse infiltrations of 255 
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neutrophils (29). The development of cellulitis in dogs is rare but cases of S. pseudintermedius-256 
mediated cellulitis have been reported with lymphatic damage linked to bacteraemia and toxic 257 
shock or necrotising fasciitis (30-32). There is little understanding as to how either an abscess or 258 
cellulitis pathology develops but it has been thought that the host immune response has a pivotal 259 
role in driving the development of each pathology (29). The work presented here suggests that 260 
bacterial surface proteins can determine the pathological outcome of infection.  261 
For S. aureus-mediated skin abscesses or micro-abscesses, formed after bloodstream 262 
infection, a number of bacterial proteins have been implicated in the development of abscesses (33). 263 
The secreted coagulase and von Willebrand-binding protein (vWbp) are required for cutaneous 264 
abscess formation in both mice and rabbits (34, 35). In addition, a sortase mutant lacking expression 265 
of CWA proteins, as well as strains with deletions of particular genes, such as clfA, have been 266 
employed to demonstrate the role of CWA proteins in the development of skin abscesses (16). 267 
However, in contrast to what we observe with SpsL in the current study, loss of expression does not 268 
lead to the development of a cellulitis pathology. These data suggest that SpsL exhibits a function 269 
not previously observed among other staphylococcal surface proteins. 270 
The most abundant extracellular matrix protein in healthy skin is collagen. However, when 271 
skin is damaged, such as during subcutaneous inoculation, the initiation of the coagulation cascade 272 
leads to platelet activation resulting in high levels of fibrinogen and fibronectin at the inoculation 273 
site (36, 37). We postulate that SpsL promotes abscess formation through the development of a 274 
fibrinogen- or fibronectin-shield on the bacterial surface that could initiate bacterial aggregation. 275 
The importance of bacterial aggregation for the initial stages of skin abscess development has 276 
already been reported for S. aureus with bacterial aggregates linked to increased bacterial load and 277 
bacterial dissemination (38). In S. aureus, this aggregation is coagulase-dependent with a lack of 278 
aggregation leading to decreased bacterial burden (38). In contrast, SpsL-dependent abscess 279 
formation results in a decreased bacterial burden at 2 and 3 dpi in comparison to the alternative 280 
cellulitis pathology (Fig. 6). The widespread conservation of the spsL gene in S. pseudintermedius 281 
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strains from across the world suggests that S. pseudintermedius could favour the development of 282 
subcutaneous abscesses rather than cellulitis (7, 13, 39, 40). Experiments performed over a longer 283 
period of time could identify if S. pseudintermedius were able to persist and avoid clearance in the 284 
SpsL-dependent abscesses in comparison to the cellulitis pathology. Additionally, bacterial 285 
aggregation could be beneficial to S. pseudintermedius in other types of infection and particularly in 286 
the initial stages of biofilm formation, which may promote colonisation and persistence on 287 
indwelling devices or atopic skin (41, 42).  288 
Ideally, the role of SpsL in abscess formation and the mechanism involved could be further 289 
examined using a canine infection model. A canine superficial pyoderma model has been developed 290 
allowing the application of bacteria onto artificially created skin abrasions (43). This model 291 
produces classical clinical signs of pyoderma including the development of pustules and dermatitis 292 
that was self-limiting (43). It would be interesting to investigate the role of both SpsD and SpsL in 293 
this model as their role in cell invasion in vivo could also be established. 294 
In conclusion, by developing the first S. pseudintermedius murine model, we have been able 295 
to examine the role of the 2 CWA proteins of S. pseudintermedius, SpsD and SpsL, in the 296 
development of cutaneous infections. We have identified that SpsL promotes the development of 297 
abscesses and this is the first description of a bacterial CWA protein influencing the type of 298 
cutaneous pathology developed during experimental infection. As so little is known about the 299 
immune mechanisms responsible for the development of either an abscess or cellulitis pathology, 300 
the model developed here could be useful for future investigations into the molecular basis of these 301 
clinical manifestations. More work into the in vivo function of virulence factors of S. 302 
pseudintermedius is needed if we aim to develop novel therapeutics to combat the increasingly 303 
multi-drug resistant clinical strains of S. pseudintermedius.   304 
  305 
 306 
Materials and Methods 307 
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Ethics Statement. All murine experiments were carried out under the authority of a UK 308 
Home Office Project License (PPL 70/08663) within the terms and conditions of the strict 309 
regulations of the UK Home Office Animals (Scientific Procedures) Act 1986 and the code of 310 
practice for the housing and care of animals supplied for scientific purposes. In all experiments 311 
female BALB/cANCrl (Charles River, hereafter abbreviated as BALB/c) mice aged between 10-12 312 
weeks were used. All mice were housed under specific pathogen-free (SPF) conditions at the 313 
Biological Research Facility (BRF) for rodents at the Roslin Institute according to hygiene 314 
recommendations of Federation of European Laboratory Animal Science Associations (FELASA) 315 
guidelines (44, 45). Mice were randomly assigned to individually ventilated home cages after 316 
arrival and acclimatised for 1 to 2 weeks in the facility before being used in infection challenge 317 
studies. Animals had, throughout maintenance and infection challenge, ad libitum access to food 318 
and water. Mice were maintained on a standard diet (Teklad Global 18% Protein Rodent Diet), at an 319 
average room temperature of 21°C and a 12:12 h light/dark cycle. All study protocols were 320 
reviewed by the Roslin Institute (University of Edinburgh) animal services, consisting of the named 321 
veterinary surgeon (NVS), the rodent facility director, and a senior research statistician, prior to 322 
each experiment. Animals were monitored twice daily to ensure that no animal exceeded agreed 323 
euthanasia criteria including a 20% loss of body weight or moderate signs of general illness. Only 324 
mild symptoms of generalised illness were noted with slight decreases in weight, some discharge 325 
from the eyes, and starring of the fur. No animal required premature euthanasia with all animals 326 
humanely euthanized at the end of experimentation by schedule 1 asphyxiation using carbon 327 
dioxide (VetTech Solutions). Euthanized animals were then subjected to cervical dislocation to 328 
ensure euthanasia.  329 
Solid Phase Adherence Assays. Solid phase adherence assays were performed as described 330 
previously (13). Briefly, murine fibrinogen (Abcam), murine fibronectin (Abcam), or recombinant 331 
murine cytokeratin-10 C-terminus (294-570) (purified as described previously (46)) were coated 332 
overnight at 4°C in PBS on 96-well MaxiSorp® plates (Nunc). Wells were blocked with 100 µl 8% 333 
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(w/v) non-fat dried milk (Fluka Analytical) for 2 h at 37°C. Lactococcus lactis strains, characterised 334 
previously (13), were cultured overnight in M17 broth (Oxoid), washed in PBS and diluted to an 335 
OD600 of 1.0 in PBS. S. pseudintermedius strains, characterised previously (15), were cultured in 336 
Brain Heart Infusion broth (Oxoid) until an OD600 of 0.6, washed in PBS and diluted to an OD600 of 337 
1.0 in PBS. Bacteria were applied to the wells in triplicate and incubated for 2 h at 30°C for L. 338 
lactis, or 2 h at 37°C for S. pseudintermedius. Bound bacteria were fixed with 100 µl 25% (v/v) 339 
formaldehyde (Sigma-Aldrich) for 30 min and then stained with 50 µl 0.5% (w/v) crystal violet 340 
(Sigma-Aldrich) for 3 min. Before analysis, 5% (v/v) acetic acid (BDH Lab Supplies) was applied 341 
and the plate read using a Synergy
TM
 HT plate reader (BioTek) at a wavelength of 590 nm.   342 
Murine Skin Infection Model. The bacterial inoculum was produced by culturing S. 343 
pseudintermedius strains to an OD600 of 0.6 in Brain Heart Infusion broth (Oxoid). 10 ml of culture 344 
was washed and then diluted in PBS to the relevant OD600 to provide 10
7
 colony forming units 345 
(CFU) per 100 µl. The size of the inoculum used for infection challenge was confirmed by CFU 346 
plating for each experiment.  347 
The dorsal midline of isoflurane anaesthetised BALB/c mice were shaved using electric 348 
clippers 24 h pre-inoculum. Bacteria were injected into the subcutaneous tissue of the dorsal 349 
midline just caudal to the intrascapular region of the BALB/c mouse in 100 µl volume using a 26-350 
gauge needle and a 5 mm needle guard to ensure standard injection depths. Mice were caged with 6 351 
or less mice per cage with at least 6 mice per experimental group. All animals were monitored for 352 
weight, length of observed lesion along the longest axis using callipers, noting the presence or 353 
absence of a lump, as well as identifying any clinical signs of illness. Measuring the longest axis of 354 
the lesion was deemed the most appropriate measure as the lesions developed were highly irregular 355 
in shape meaning that measurement of lesion width was very subjective. Mice were humanely 356 
euthanized at 1, 2, 3, or 4 days post-infection (dpi). Spleens and skin lesions were immediately 357 
excised and immersed in 10% formal buffered saline (Fisher Scientific) for histopathological 358 
analysis. All experiments were repeated at least twice giving the same results.  359 
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Skin lesions were trimmed and histopathology slides produced by the Pathology Department 360 
of the Royal Dick School of Veterinary Studies, University of Edinburgh using routine methods. 361 
Histology slides were stained with hematoxylin and eosin (H&E) giving nuclei a blue staining and 362 
proteinaceous material a pink staining. Histopathology slides were analysed blind for lesion length 363 
along the longest axis using a magnifying glass and callipers, as well as disease severity and 364 
categorised depending on the type of pathology present (abscess/cellulitis). This analysis was 365 
independently performed by two persons before unblinding. All histopathology slides included for 366 
analysis contained the following 5 layers of skin: epidermis, dermis, panniculus, panniculus 367 
carnosus muscle, and adventitia. Histopathology slides were removed from the analysis if only 368 
superficial layers of the skin were present on the slide.  369 
For colony forming units (CFU) determination, after excision of the skin lesion, the area was 370 
sliced into equal sections using a scalpel. These skin sections (containing the whole of the skin 371 
lesion) were suspended in 1 ml PBS in Lysing Matrix D tubes containing 1.4 mm ceramic spheres 372 
(MP Bio). After calculating the weight of the skin lesion, homogenisation of the skin samples were 373 
performed by pulsing the samples at 4.0 m/sec twice for 20 s per pulse with a minute break between 374 
pulses. Triplicate serial dilutions were produced per homogenate and plated for CFU enumeration. 375 
Histopathology Severity Scoring. The overall severity of pathology present on the 376 
histopathology slide was scored using the following system: grade 0, minimal pathological changes; 377 
grade 1, mild inflammatory changes with a mild increase in the number of neutrophils and 378 
lymphocytes present in the panniculus and deeper connective tissue layers; grade 2, moderate 379 
pathology with formation of either a focal, well-defined abscess in the skin accompanied by 380 
inflammation in surrounding tissues or a laterally-oriented cellulitis with a poorly defined 381 
accumulation of neutrophils and cell debris extending between the tissue planes; grade 3, marked 382 
pathology displaying more extensive pathology with the abscess or cellulitis effacing a larger area 383 
of the section and overlying epidermal ulceration often noted; and grade 4, severe pathology with 384 
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large abscess or cellulitis formation, epidermal ulceration, and disruption of normal tissue 385 
architecture.  386 
Generation of ED99∆spsL Repaired Strain. Sequence ligase independent cloning was 387 
used to clone the full length spsL gene, along with 500 bp flanking regions, into the temperature-388 
sensitive allele replacement vector pIMAY as previously described (47, 48). A synonymous 389 
mutation was introduced into the N-terminal region of the spsL gene to allow identification in 390 
comparison to the wildtype (primer sequences are given in Table S1). The pIMAY plasmid 391 
containing the mutated spsL gene was electro-transformed into the S. pseudintermedius ED99∆spsL 392 
background at 28°C with selection on 10 µg/ml chloramphenicol. Growth at 37°C selected for 393 
plasmid integration before plasmid excision at 28°C. The anti-sense secY mechanism was found to 394 
be non-functional in S. pseudintermedius as previously described (15). The generation of the 395 
ED99∆spsL Rep strain was confirmed by PCR and Sanger sequencing as well as Western blot 396 
analysis. CWA protein profiles of strains cultured to an OD600 of 0.6 in Brain Heart Infusion broth, 397 
produced as described previously (15), were probed with 1 µg/ml anti-SpsL N2N3 IgY and 0.5 398 
µg/ml F(ab’)2 rabbit anti-chicken HRP-conjugated IgG (Bethyl Laboratories).  399 
Statistical Analysis. Prism 6 (GraphPad) was employed to present data with statistical 400 
analysis performed using Minitab 16. The data of each experiment and each time point was 401 
analysed separately with data between time points not pooled except to analyse the pathology type 402 
data. The Anderson-darling test was used to assess data normality and equal variance. Data 403 
transformation was performed if required and analysed using either a 2-sample unpaired t-test or 404 
one-way ANOVA analysis with multiple comparisons performed when appropriate. If the data 405 
could not be successfully transformed, nonparametric analysis was performed including Kruskal 406 
Wallis or Mann-Whitney U test analysis. For analysis of severity grading, ordinal logistic 407 
regression was performed with pathology type data being analysed in pairs using Fisher’s exact 408 
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analysis. For data displaying statistical significance: * represents p≤0.05, ** represents p≤0.01, and 409 
*** represents p≤0.001. 410 
 411 
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Figure Legends 564 
FIG 1 SpsD and SpsL promote adherence to murine fibronectin, fibrinogen, and cytokeratin-10. 565 
Bacterial solid phase adherence assays of stationary phase (A) L. lactis expressing SpsD, and (B) L. 566 
lactis expressing SpsL to murine fibronectin, fibrinogen, and cytokeratin-10. Bacterial solid phase 567 
adherence assays of ED99 wildtype (WT) (closed circle), ED99∆spsD (open square), ED99∆spsL 568 
(closed triangle), and ED99∆spsL∆spsD (open triangle) to (C) murine fibronectin, (D) murine 569 
fibrinogen, and (E) murine cytokeratin-10 at early exponential growth phase (OD600 of 0.2). Each 570 
data point represents the mean value from three independent experiments; error bars represent SD.  571 
 572 
FIG 2 S. pseudintermedius ED99-infected mice develop skin abscesses. Monitoring data is shown 573 
as (A) percentage change in body weight and (B) surface lesion length (mm) for ED99 wildtype 574 
(WT)-infected mice (black circle) and PBS-control mice (open triangle). Each data point represents 575 
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an individual mouse. Mean scores (horizontal bars) were analysed by two-sample unpaired t-test, 576 
*p≤0.05 and **p≤0.01. (C and D) Representative images of H&E-stained skin sections of a PBS-577 
control mouse and a WT-infected mouse at 4 dpi. A hair follicle and all 5 layers of the skin are 578 
labelled in the PBS-control section. The WT section contains a large, well circumscribed abscess in 579 
the deeper layers of the skin. The abscess is composed of a necrotic centre surrounded by a 580 
concentric ring of neutrophils and cellular debris, and accompanied by suppurative dermatitis, 581 
panniculitis, myositis, and myofibre degeneration.   582 
 583 
FIG 3 Infection with S. pseudintermedius ED99 deficient in SpsD and SpsL leads to the 584 
development of large surface lesions and cellulitis. Monitoring data is shown as (A) percentage 585 
change in body weight and (B) surface lesion length (mm) for WT- (black circle) and 586 
ED99∆spsL∆spsD-infected mice (open circle). Each data point represents an individual mouse and 587 
data are representative of a single replicate of experiments performed twice. Mean scores 588 
(horizontal bars) were analysed by two-sample unpaired t-test. (C) Representative images of H&E-589 
stained skin sections of WT-infected or ED99∆spsL∆spsD–infected mice at 3 dpi. The WT-infected 590 
mice display a focal abscess. The ED99∆spsL∆spsD–infected mice display a horizontally oriented 591 
inflammation throughout the panniculus carnosus muscle layer akin to cellulitis. Magnification (by 592 
100x) of the areas indicated by black rectangles demonstrate that regions of inflammation are 593 
composed predominantly of degenerate neutrophils admixed with cellular debris, in all 594 
experimental groups. (D) Histopathology lesion length (mm). (E) Number of mice demonstrating 595 
each pathology type. No abscesses were documented in the ED99∆spsL∆spsD–infected mice and 596 
the inflammation present is more longitudinally extended than in WT-infected mice. Fisher’s exact 597 
analysis demonstrates differences in infection outcome between WT- and ED99∆spsL∆spsD-598 
infected mice. Significant results are represented as * p≤0.05, **p≤0.01 and ***p≤0.001. 599 
 600 
 o
n
 Septem
ber 10, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
22 
 
FIG 4 SpsL is required for S. pseudintermedius abscess formation. Monitoring data is shown as (A) 601 
percentage change in body weight and (B) surface lesion length (mm) for WT- (filled circle), 602 
ED99∆spsL∆spsD- (open circle), ED99∆spsD- (filled square), or ED99∆spsL-infected mice (open 603 
square). Each data point represents an individual mouse and data are representative of a single 604 
replicate of experiments performed twice. Mean scores (horizontal bars) were analysed by one-way 605 
ANOVA. (C) Histopathology lesion length (mm) was analysed by Kruskal-Wallis. (D) The number 606 
of mice demonstrating each pathology type. Fisher’s exact analysis demonstrates differences in 607 
infection outcome between each experimental group compared to every other experimental group. 608 
Significant results are represented as * p≤0.05, **p≤0.01 and ***p≤0.001. 609 
 610 
FIG 5 Reintroduction of spsL to S. pseudintermedius restores the abscess phenotype. (A) 611 
Percentage change in body weight. Mean scores (horizontal bars) were analysed by one-way 612 
ANOVA. (B) Histopathology lesion length (mm). Mean scores were analysed by Kruskal-Wallis. 613 
(C) The number of mice demonstrating each pathology type. Fisher’s exact analysis demonstrates 614 
differences in infection outcome between each experimental group compared to every other 615 
experimental group. (D) Log CFU/lesion. Mean values were analysed by one-way ANOVA with 616 
Tukey’s multiple comparison analysis. Each data point represents an individual mouse with WT- 617 
(filled circle), ED99∆spsL- (open square), or ED99∆spsL Rep-infected mice (filled triangle). 618 
Significant results are represented as *p≤0.05, **p≤0.01, and ***p≤0.001.  619 
 620 
FIG 6 The cellulitis pathology induced by S. pseudintermedius deficient in SpsL is associated with 621 
increased bacterial numbers. The number of CFU were analysed after homogenisation of the 622 
excised and trimmed skin lesion. The logged CFU/lesion data is plotted with each data point 623 
representing an individual mouse for WT- (filled circle), ED99∆spsL∆spsD- (open circle), 624 
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ED99∆spsD- (filled square), or ED99∆spsL-infected mice (open square). Mean values (horizontal 625 
bar) were analysed by one-way ANOVA with Tukey’s multiple comparison analysis, **p≤0.01, and 626 
***p≤0.001. Mice infected with bacterial strains lacking the spsL gene have increased bacterial 627 
burdens at 2 and 3 dpi.  628 
 629 
 630 
 631 
 632 
 633 
 634 
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